
Odefsey is the smallest single tablet regimen to treat patients 12-years-old and above infected with HIV.

Odefsey is the smallest single tablet regimen to treat patients 12-years-old and above infected with HIV.

This case is the first reported failure for pre-exposure prophylaxis to stop HIV infection.

The FDA has approved emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg as a new treatment for HIV-1 infection in certain patients.

A gay man has been infected with HIV despite taking Truvada every day for 2 years.

Charlie Sheen's announcement that he is HIV-positive may lead to a new era of HIV preventative efforts.

Sites and apps such as Grindr, Manhunt, Scruff, Adam4Adam, and Craigslist may be linked with higher STD incidences.

Personal concerns about HIV status jeopardizing existing relationships could affect patient adherence behaviors.

Stigma remains a serious concern for patients living with HIV.

New HIV treatment approach scrambles DNA to stop it from multiplying.

Researchers explore possible reasons why HIV-positive patients have a decreased risk of MS.

HIV protein can impair neurocognitive function in nearly half of HIV-positive patients.

Antiretroviral therapy taken early and frequently can limit the spread of HIV.

Large proportion of high risk young adults are unaware they are infected with HIV.

RNA-based drug infiltrates the virus to prevent HIV from replicating.

Adenosine deaminase could help activate the immune system to rapidly fight and eliminate HIV.

Smoking puts HIV patients at greater risk of developing co-morbidities.

HIV viral reservoir widely considered the last barrier to a cure.

Complera treats HIV infection in previously untreated adults with a viral load of 100,000 copies/mL or less.

Johns Hopkins will be the first hospital in the US to administer an HIV-positive kidney transplant and the first in the world to perform an HIV-positive liver transplant.

Treatment errors in HIV therapy injure thousands of patients annually.

Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.

One common method of HIV transmission is sharing needles for intravenous drug use.

Cistus incanus found to inhibit viral proteins from infecting healthy cells.

Research explores how HIV is able to evolve during antiretroviral therapy.

Study finds the greatest access to cost-sharing reduction subsidies translated to the lowest costs for patients with HIV.